99 related articles for article (PubMed ID: 2669768)
21. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
[TBL] [Abstract][Full Text] [Related]
22. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
Goossens HA; van den Bogaard AE; Nohlmans MK
Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
[TBL] [Abstract][Full Text] [Related]
23. Comparison of immunofluorescence and enzyme linked immunosorbent assays for diagnosing Lyme disease.
Cutler SJ; Wright DJ
J Clin Pathol; 1989 Aug; 42(8):869-71. PubMed ID: 2671054
[TBL] [Abstract][Full Text] [Related]
24. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
[TBL] [Abstract][Full Text] [Related]
25. Recombinant or peptide antigens in the serology of Lyme arthritis in children.
Heikkilä T; Huppertz HI; Seppälä I; Sillanpää H; Saxen H; Lahdenne P
J Infect Dis; 2003 Jun; 187(12):1888-94. PubMed ID: 12792865
[TBL] [Abstract][Full Text] [Related]
26. Immunochemical analysis of Lyme disease spirochetes.
Barbour AG
Yale J Biol Med; 1984; 57(4):581-6. PubMed ID: 6393610
[TBL] [Abstract][Full Text] [Related]
27. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
Jobe DA; Lovrich SD; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
[TBL] [Abstract][Full Text] [Related]
28. Cross-reactivity between Lyme and syphilis screening assays: Lyme disease does not cause false-positive syphilis screens.
Patriquin G; LeBlanc J; Heinstein C; Roberts C; Lindsay R; Hatchette TF
Diagn Microbiol Infect Dis; 2016 Mar; 84(3):184-6. PubMed ID: 26707064
[TBL] [Abstract][Full Text] [Related]
29. [3M Fast-Lyme test in the diagnosis of Lyme disease in Poland].
Knap J; Raczka A; Anusz Z; Bartoszcze M; Mierzejewski J; Dabrowski Z
Pneumonol Alergol Pol; 1991; 59 Suppl 1():69-74. PubMed ID: 1843814
[No Abstract] [Full Text] [Related]
30. Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease.
Bryksin AV; Godfrey HP; Carbonaro CA; Wormser GP; Aguero-Rosenfeld ME; Cabello FC
Clin Diagn Lab Immunol; 2005 Aug; 12(8):935-40. PubMed ID: 16085911
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing Lyme disease: the contribution of serologic testing.
Duffy J; Mertz LE; Wobig GH; Katzmann JA
Mayo Clin Proc; 1988 Nov; 63(11):1116-21. PubMed ID: 3193820
[TBL] [Abstract][Full Text] [Related]
32. Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.
Embers ME; Jacobs MB; Johnson BJ; Philipp MT
Clin Vaccine Immunol; 2007 Aug; 14(8):931-6. PubMed ID: 17567769
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.
Callister SM; Schell RF; Case KL; Lovrich SD; Day SP
J Infect Dis; 1993 Jan; 167(1):158-64. PubMed ID: 8418162
[TBL] [Abstract][Full Text] [Related]
34. [Usefulness of the 3M Fast-Lyme test in the early diagnosis of borreliosis].
Borowska SC; Szymański W; Rogalewska A; Michalska I; Kowal K
Pneumonol Alergol Pol; 1991; 59 Suppl 1():65-8. PubMed ID: 1843813
[No Abstract] [Full Text] [Related]
35. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
Bradshaw GL; Thueson RK; Uriona TJ
J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
[TBL] [Abstract][Full Text] [Related]
36. Editorial commentary: laboratory testing for Lyme disease: time for a change?
Weinstein A
Clin Infect Dis; 2008 Jul; 47(2):196-7. PubMed ID: 18532894
[No Abstract] [Full Text] [Related]
37. Epidemiologic features of Lyme disease in New York.
Hanrahan JP; Benach JL; Coleman JL; Bosler EM; Grabau JC; Morse DL
Yale J Biol Med; 1984; 57(4):643-50. PubMed ID: 6334940
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease.
Mogilyansky E; Loa CC; Adelson ME; Mordechai E; Tilton RC
Clin Diagn Lab Immunol; 2004 Sep; 11(5):924-9. PubMed ID: 15358654
[TBL] [Abstract][Full Text] [Related]
39. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
Christova I
Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
[TBL] [Abstract][Full Text] [Related]
40. Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi.
Magnarelli LA; Anderson JF
Am J Epidemiol; 1988 Apr; 127(4):818-25. PubMed ID: 3354546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
